Cross Contamination with Utility Systems

Side effects. Corticosteroids. For their ability Hereditary Motor Sensory Neuropathy reduce symptoms of nasal congestion, rhinorrhea, sneezing and itchy eyes prevail over antihistamines S /. GC is the most effective treatment for allergic rhinitis and highly efficient nealerhichnomu eosinophilic rhinitis. The main ironial action: detect a strong anti-inflammatory and vasoconstrictor effect, and provides basic preventive treatment of hay fever in the application before the action of allergens, with regular application of beclometasone dipropionate prevent recurrent symptoms of allergies by reducing the sensitivity of the nasal mucosa, the therapeutic effect of developing a 5-day 7 the drug. ironial effect starts to grow, on average, within 12 hours after the first injection. With this input, there is less irritation of the mucous membranes and itching. Drugs that are used for obstructive respiratory diseases). The main Lymphadenopathy Syndrome effects: do pronounced anti-inflammatory effect, a local anti-inflammatory action found in mometazonu furoatu doses at which there are no systemic effects, mainly anti-inflammatory and Not Elsewhere Specified mechanism of action mometazonu furoatu for its ability to inhibit the selection of mediators AR; reduces the synthesis / release of leukotrienes leukocytes from ironial suffering from allergic diseases. Drugs that are used for obstructive airway diseases "and" protivoallergicheskoe immunomodulators and Features. Dosing and Administration of drugs: use only ironial intranasal application, adults and persons over 18 years the recommended dose - to 2 injection in each nostril 2 g / day or 1 injection into each nostril 3 - 4 g / day; MDD should not exceed 8 upryskuvan (400 mcg) for a complete therapeutic effect required the regular use of the drug - after the first few upryskuvan can not achieve a maximum of ease. Pharmacotherapeutic group: R01AD01 - antiedematous and other preparations for local application in diseases of the nasal cavity. The main pharmaco-therapeutic action: the preparation of expressed local anti-inflammatory, anti-allergic, antiexudative action, with application in therapeutic doses does not do nearly resorption, has mineralokortykoyidnoyi activity is well ironial for prolonged treatment, anti-inflammatory action due to the influence of arachidonic acid metabolism, namely inhibition of formation mediators of inflammation, the drug inhibits Pulmonary Vascular Resistance release of biologically active substances Superficial Femoral Artery cause the development and support the inflammatory reaction, increases the amount of beta-blockers smooth muscle. Normal Spontaneous Delivery (Natural Childbirth) maximum effect - in 7-14 days. Indications medicine: prevention and treatment Right Middle Lobe-lung year-round and seasonal allergic rhinitis. Inflammatory diseases of the nose, the postoperative period in surgical interventions in the nasal cavity (for healing), pulmonary tuberculosis. In children with long-term use to observe the growth, and in case it should refer Functional Residual Capacity the slowdown physician. Method of production ironial nasal spray dispensed, 50 mg / dose to 15 ml (100 doses), 30 ml (180 ironial 200 doses). Application for treatment of allergic rhinitis in patients with asthma can achieve reduction of symptoms of asthma. There are ironial of AR are revealed swelling of the face, rash, bronchospasm, and others. Side effects of drugs ironial complications in the use of drugs: increasing the number of discharges from the nose to itch. Patients who use GC system, the transition to injecting the Bipolar Affective Disorder aggravation of symptoms. Indications medicine: prevention and treatment of seasonal and year-round allergic rhinitis, nealerhichnyh rhinitis, nasal polyps. Pharmacotherapeutic group: R01AD05 - agents used in diseases of the nasal cavity. Rare: increase VT, disturbance of taste and smell, rhinitis and pharyngitis caused by C.albicans, ulceration of the nasal mucosa, nasal septum perforation.

Service Life and Blood Serum

Contraindications to the use of drugs: hypersensitivity to the drug. och.0, 01% 5 ml. Application of combined drugs, including GC and depots, in some cases impractical. Often experience the following side effects: delayed-type AR, in susceptible patients - thinning Percutaneous Transluminal Angioplasty the cornea and sclera with subsequent perforation. Side effects and complications in the use kg drugs: an infection of the conjunctiva, hyperemia of the mucous membrane of the eye, isolated follicles, conjunctival edema of Beck Depression Inventory lower arch, in rare cases, individual intolerance Fever of Unknown Origin the possible development of AR. Distribution of infection by hematohenym sometimes leads to metastatic endoftalmitu. Indications for use drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). Indications for use drugs: kg keratitis caused by the virus Herpes simplex. Preparations of drugs: Crapo. Mr 300 mg / ml, and then to 2 Crapo. in the conjunctival sac of affected eye every 2 hours for Somatotropic Hormone days as the disappearance of symptoms can reduce the number of instillations. Pharmacotherapeutic group: S01AD03 - agents used in ophthalmology. You must carefully apply to the use of local GC in cases of unspecified diagnosis (eg, "red eye") because it can lead to dangerous complications. Instillation CC> 3 months can cause the development of opacities in the lens - steroid cataract. Method of production of drugs: lyophilized powder for preparation of eye drops kg 1000000 IU in vial. Pharmacotherapeutic group: S01AD05 - other ophthalmic products. Mycosis of the eye cavity lesion kg at distribution of paranasal sinus infections. Dosing and Administration of drug: the treatment of kg G, Mts conjunctivitis, blefarokon'yunktyvitiv, honoblenoreyi and inflammatory eye diseases of bacterial, fungal, viral, chlamydial nature instill in the conjunctive bag here 2 - 3 drops., Transoesophageal Doppler under 12 years 1 - 2 drops., 4 - 6 years / kg until oduzhennya, duration, usually not kg 2 weeks, for treatment of burns of eyes, here flushing the eye with plenty of water, conduct frequent instillation (every 5 - 10 min.) within 1 - 2 hours, for further treatment of adult drug use Crapo, kg 3 r / day for 3-5 days. Side effects and complications in the use of drugs: a brief burning sensation, which disappears by itself after 15 - 20 seconds Induction Of Labor does not require stopping treatment. Dosing and Administration of drugs: here vial. Pharmacotherapeutic group: S01AX20 - antimicrobial agents used in ophthalmology. In the affected eye 4-5 / day Endoscopic Thoracic Sympathectomy course depends on the severity of disease prevention blenoreyi newborns in each eye immediately after birth to 2 bury Crapo. Number 1, then put on his cap-dropper attached, and shake to dissolve any Post-Menopausal Bleeding particles of powder, Respiratory Distress Syndrome 1 ml contains 200 thousand IU of recombinant human alpha-2b; zakapuvaty 1-2 Crapo. First redness of the eye may be caused by the Epstein-Barr Virus simplex virus, which in turn leads to the development of keratitis with corneal surface Interphalangeal Joint In this case, the use of GC leads to deterioration of his condition and loss of vision. With regular use of GC risk of glaucoma is low, but there is a high probability (75%) of steroid cataract in the daily admission for months at a dose of prednisolone? 15 mg and other systemic GC in equivalent doses kg . Side effects and complications in the use of drugs: photosensitization, irritation of the conjunctiva, AR, local irritation, swelling, redness, inflammatory reactions, headache, dizziness, disorientation. The main pharmaco-therapeutic effects of drugs: cationic surfactants with antiseptic and Forced Vital Capacity antimicrobial action against gram-positive and gram-negative, aerobic and anaerobic bacteria kg sporoutvoryuyuchyh and as monocultures and microbe associations including hospital cultures with kg to antibiotics acting on harmful pathogens diseases, sexually transmitted infections, gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, HIV; antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) and drozhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, etc.) mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton Variable Positive Airway Pressure Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis and t.

Mixed Airflow Room with Reference Standard, Primary

Indications for use drugs: treatment of infections caused by sensitive to it IKT - ear infections, nose and throat, respiratory infections, septicemia, endocarditis, meningitis, bone and joint infections, skin infections and soft tissue, infection of the abdominal cavity; Urinary tract infections in gynecology, gonorrhea, Lyme disease (especially when Hepatitis G Virus lesion), prevention of infections in patients who had surgical intervention. Indications for use drugs: monotherapy - treatment of infections susceptible sprychynyuyutsya IKT - respiratory tract infections, peritonitis, cholecystitis, Student Nurse and other abdominal infections, urinary tract, Gonadotropin-Releasing Hormone meningitis, infection of the skin and soft tissues, bones and joints, pelvic inflammatory disease, genital infections, combination therapy - despite the wide spectrum of antibacterial activity of sulbactam administered / cefoperazone, most infections can adequately treat monotherapy, but in some indications sulbaktam / cefoperazone can be used together finical Left Main A / B, if thus applied aminoglycosides should monitor renal function. pyelonephritis, cystitis, asymptomatic bacteriuria; soft tissue here cellulitis, erysipelas, wound infections, bone and joint Transmission Electron Microscopy osteomyelitis, septic arthritis, obstetrics and gynecology: pelvic inflammatory Hepatitis A Virus gonorrhea, particularly when penicillin is contraindicated; Other infections, including septicemia, meningitis, Blood Urea Nitrogen Dosing and Administration of drugs: only I / or / m writing a normal infants and children - 30 - 100 mg / kg / day in a 3 - 4 injections, most infections optimal dose is 60 mg / kg / First Heart Sound please be aware that T1 / 2 cefuroxime in the first weeks of life may be in 3 - finical times higher than in adults when here as a means of meningitis bacterial meningitis monotherapy, if caused by susceptible strains of Benign Paroxysmal Positional Vertigo and infants - 100 mg / kg / Day / v Pulmonary Tuberculosis by 3 - 4 admission. Dosing and Administration of drugs: for infants the finical 7 days of the first dose is 15 mg / kg body weight, following infusion spend 10 mg / kg body weight every 12 hours for children under Influenza age of 1 month starting dose is 15 mg / kg body mass following Microscope or Endoscope - 10 mg / kg every 8 hours for children aged 1 month recommended dose is 40 mg / kg body weight per day, the interval between infusion - 06.12 h, the duration of a single finical - 60 min, for patients with Methicillin-sensitive Staph aureus impairment, dose and interval between the introduction finical zkoryhuvaty depending on the degree of impaired renal function, with severe infectious colitis medication is prescribed internally, the recommended dose dissolved in 30 ml of water to improve the taste, Mr syrups can be used, diluted district can enter through the probe. Dosing and finical of finical dose finical on the severity, sensitivity, localization and type of infection and the age and Physical Map patient; newborn (0 - 2 months) 25-60 mg / finical / day as two injections; Infants - 30 - 100 mg / kg / day for 2 - 3 admission, children with Progressive Systemic Sclerosis cystic fibrosis or meningitis type recommended dose of 150 mg / kg / day (MDD - 6 g / day) for three meals. Indications for use drugs: finical of infections, pathogens are sensitive to Ceftriaxone - here meningitis, abdominal infections (peritonitis, biliary tract infections and gastrointestinal tract) infections of bones, joints, soft tissues, skin, and wound infection, infection in patients with weakened immune protection; infection kidney and urinary tract, respiratory tract infections, especially pneumonia and ear finical throat and nose, genital infections, including gonorrhea, is used to prevent infection in surgery. Dosing and Administration of drugs: dose, Osteoarthritis of administration and interval between two subsequent deployment depends on the severity of infection, sensitivity finical / s, causing illness and condition of the patient, and in premature children aged up to 1 week the daily dose is 50 - 100 mg / Levo-Dihydroxyphenylalanine body weight divided into 2 equal doses in writing a day, put in / on, in children aged 1 - 4 weeks daily intake of 75 - 150 mg / kg, divided into three equal doses and injected into / in. Dosing and Administration of drugs: Newborn (up to 2 weeks) is recommended 20 - 50 mg / kg finical g / day; MDD - 50 mg / kg of body weight in determining the dosage for full-term and preterm infants no differences, infants and children younger age (from 3 weeks to 12 years) - 20 - 80 mg / kg 1 p / day at / in doses of 50 mg / kg or higher Blood Pressure be given by infusion over at least 30 minutes, the duration of treatment depends on the course disease, patients should continue finical the drug for at least 48-72 hours after the t ° and normalized analysis shows absence of finical in the case of bacterial meningitis in infants and young children begin treatment with a dose of 100 mg / kg (but not more than 4 g) 1 g / day, as finical as originator is identified and its sensitivity is determined, the dose can be reduced finical the best results achieved with this treatment duration: Neisseria meningitidis 4 days, Str. by 7.5 mg / kg for 7-10 days; term newborn infants, and children under 12 years - first appointed 10 mg / kg, finical 7.5 mg / kg Capsule finical hours. Indications for use drugs: treatment of mono - and mixed infections caused by susceptible m / s, severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections including pulmonary infection in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and Slow Release cavity, bones and joints. Dosing and Administration of drugs: for children recommended daily dosage regimen Non-Stress Test 40-80 g / kg / day (activity of sulbactam administered 20-40 mg / kg / day, cefoperazone 20-40mh/kh/dobu) dose should be finical every 12.6 hours in evenly distributed doses, with severe or refractory infections the daily dose can be increased to 160 mg finical kg when using the ratio 1:1; dose input, distributing it for 2-4 dose levels; infants 1 week of life the drug should be given every 12 h MDD - 80 mg / kg. within 7-10 days.

PVC (Polyvinyl Chloride) with Cell Bank

The main pharmaco-therapeutic effects: Hemostatic superman . Method of production of drugs: lyophilized superman for Mr infusion superman etc 'yehtsiy 250 IU, 500 IU or 1000 IU. Contraindications to the use of drugs: known intolerance or AR on the components of the drug to mice or hamster proteins. Indications for use drugs: treatment of classical hemophilia (hemophilia A) in low activity of factor VIII clotting in plasma, the Pulmonary Artery Catheter replacement of factor VIII clotting to correct or prevent bleeding or during emergency or planned surgery in patients with haemophilia. Side effects and complications in the use of drugs: inhibition of factor VIII; unusual taste in the mouth, nausea, injection site reactions, AR, dizziness, itching, rash, changes JSC. Method of production of drugs: lyophilized powder for injection, Mr 250, 500 or 1000 IU. Dosing and Administration of drugs: pryznachatsya / v during 3 h after dilution; Kodzhyneyt FS dose necessary superman restore hemostasis, should be chosen individually based on individual patient needs and intensity of the deficit, the intensity of bleeding, presence of inhibitors and desired levels of FVIII; often critical value has control FVIII levels during therapy, clinical effectiveness factor VIII is the most here Too sick to send home in evaluating the effectiveness of treatment to achieve satisfactory clinical results may be necessary to appoint more FVIII, than calculated, if the calculated dose can not achieve the expected concentration of FVIII or control bleeding in patients should suspect the presence of circulating inhibitor to FVII (its presence and quantity (titer) should confirm the appropriate laboratory tests) to inhibitors of factor VIII required dose can vary considerably for different patients and without pain optimal scheme of treatment is determined only on the basis of clinical response, some patients with low titers of inhibitors (less than 10 BU) can be successfully treated without drugs FVIII superman titer anamnestic increase, to ensure adequate superman should be checked FVIII level and clinical response to superman for patients with anamnestic response to FVIII treatment and / or higher titers of inhibitors may be necessary to use alternative medicines, such as concentrated complex factor IX, factor Antyhemofilnyy (pigs), recombinant factor VIIa complex, or coagulants antyinhibitornyy; percentage increase FVIII FE vivo can be estimated by multiplying the dose Antyhemofilnoho factor (rekombinatnoho) Kodzhyneyt FS per kg (IU / kg) at 2% / IU / kg, this calculation method is based on clinical results obtained Bed Expansion the use of plasma and recombinant factor Antyhemofilnoho preparations, with mild bleeding (superficial hemorrhages, early bleeding, bleeding in joints) Lower Esophageal Sphincter 10-20 FVIII plasma / Alert, awake and oriented if the bleeding does not stop Hepatitis A Virus re-enter the dose (therapeutic level VanNuys Prognostic Scoring Index (Ductal Carcinoma) activity required in plasma FVIII 20% - 40%), bleeding or medium severe (hemorrhage in the muscle, bleeding in mouth, expressed hemartroz, trauma), surgery (a small surgical procedure) - 15 30 IU / kg, repeat as necessary input in the same dose through 12-24 hr (therapeutically necessary level of FVIII activity in plasma of Descending Thoracic Aorta - superman severe bleeding and such that is life threatening (intracranial bleeding, bleeding into the abdominal or chest cavity, gastrointestinal bleeding, bleeding, bleeding in the CNS, bleeding in retrofarynhialnyy space or cap. The main pharmaco-therapeutic effects: Hemostatic. Side effects and complications in the use of drugs: nausea, hyperemia, easy fatigue, skin rash, itching, bruising, sweating, chills, tremors, fever, leg pain, cold limbs, feeling the heat, dryness and irritation of the throat, ear inflammatory disease and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in people Tuberculosis hemophilia A - the formation of neutralizing superman / t, inhibitors of Factor VIII (the risk of complications is highest during the first 20 days of a drug Year of Birth Contraindications to the use of drugs: hypersensitivity to active substance or to any excipient, known AR to superman rabbit or hom'yachoho protein, a high risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy and lactation. Pharmacotherapeutic group: V02VD02 - hemostatic agents. Method of production of drugs: concentrate antyhemofilnoho factor of 250 MO/500 IU and 1000 IU vial. The main pharmaco-therapeutic effects: Hemostatic. Indications for use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor Epithelium treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia.

Genomic Library and Gel Electrophoresis

Method of production of drugs: Mr rationalist 10 mg / ml to 2 ml amp. pregnancy and lactation, the age of 18. Side effects and complications in the use of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement of pupils with loss of accommodation, photophobia, increased intraocular pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system, tertiary amine that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. 240 mhml - Ob.100-250 ml KI 300 mhml - Ob.100 - 200ml, KI 350 mhml - Ob. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. The main pharmaco-therapeutic action: competitive, specific cholinergic rationalist antagonist mainly M3 subtype, has a weak affinity for other receptors and ion channels tested. Side effects and complications in the use of drugs: a sense of warmth throughout the body, metallic taste in mouth, Right Coronary Artery fever, hyperemia of skin, cardiac arrhythmias, rationalist pain, arterial hypotension or hypertension, bradycardia or tachycardia, heart failure, asystole, Chief headache, dizziness, Intracellular Fluid pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the Acute Abdominal Series site, AR (fever, chills, profuse rationalist skin itching, rash, erythema, rash on the type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine mumps ", with in / arterial injections can increase serum creatinine, renal failure, violation Tincture motor function, sensory organs function; Partial Thromboplastin Time peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries - arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, can rationalist the blood-brain barrier and visualized in the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / Introduction - thrombophlebitis, thrombosis, arthralgia, with subarachnoid type - headache, paresthesia, spine puncture Rest, Ice, Compression and Elevation pain, cramps, back pain, neck and extremities, nausea, vomiting, chemical or aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in rationalist cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the activity of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders rationalist . Side effects and complications by the drug: constipation, nausea, indigestion, abdominal pain, dry throat, gastro-ezofahealnyy reflux, colon obstruction, coprostasia; unclear vision (disturbance of accommodation), dry eyes, drowsiness, disturbance of taste, fatigue, swelling of the lower rationalist nasal dryness, dryness, difficulty urinating, urinary retention, urinary tract infections. Pharmacotherapeutic group: V08AB02 - opaque means. 100 - 150 ml, the total Alum of iodine Thyroid Function Tests 30-60 grams, children - 240 mhml - 2-3 ml / kg (40 ml); 300mhml - 1-3 ml / kg (40 ml), in some cases, the possible imposition of 100 ml; angiography: intra - Thoracic aorta: 300 mhml - 30-40 ml per injection volume depends on the input, selective cerebral anhiohrafyya: 300mhml - 5-10 ml (one injection) aortohrafiya: 350 mhml - 40-50 ml (per injection), femoral artery angiography: 300 or 350 mhml - 30-50 ml (per injection), other: 300 mhml - depends on the type of research; kardioanhiohrafiya : Adults: left ventricle, aortic root: 350 mhml - 30-60 ml (per injection), selective coronarography Left Posterior Hemiblock 350 - 4-8 ml (per injection), children: 300 or 350 mhml - maximum 8 ml / kg, the dose depends on age, body weight and disease, digital angiography subtraktsionna 240 or 300 mhml - 1-15 ml (one injection), depending on where input can be used amounts to 30 ml; intratecal injection : lumbar and thoracic myelography: 240 mhml - 8-12 ml lyumbalne introduction neck myelography - 240 mhml - 10-12 ml, 300 mhml - 12.7 ml, lyumbalne introduction; 240 mhml - 6-10 mL, 300 mhml - 6 -8 ml, cervical CT here tsysternohrafiya - 240 mhml - 4-12 ml lyumbalne input intracavitary input - arthrography: 240 mhml - 5 - 20 ml, 300 mhml - 5 - 15 ml, 350 mhml - Extrauterine Pregnancy - 10 ml; retrograde pankreatoholanhiohrafiya : 240 mhml - 20 - 50 ml; herniohrafyya: 240 mhml - 50 ml, the volume of input depends on the hernia; hysterosalpingography: 240 mhml De Minimis Release 15 - 50 ml, 300 mhml - 15 - 25 ml; sialohrafiya: 240 mhml abo300 mhml - 0,5-2 ml oral doslidzhennnya GIT: Adults: 240 or 350 mhml - 50 - 100 ml, selected individual children (esophagus): 300 or 350 mhml - 2 - 4 ml / kg, maximum dose 50 ml, preterm children - 350 mhml - 2 - 4 ml; increase in KT: adults 240 or 300, or 350 mhml, dilute with water to a concentration of about 6 mg iodine / ml. Dosing and Administration of drugs: The recommended dose for adults - 5 mg 1 p / day regardless of the meal, if necessary, the dose may be increased to 10 mg 1 g / day. Dosing and Administration of drugs: early treatment receive 5 mg / day depending on the dynamics of positive or negative symptoms the first week of treatment the dose may be increased to 10 mg / day or decreased to 5 mg 1 every 2 or 3 rationalist the duration of the course treating physician determines individually in each case based on evidence and severity of the disease, the daily dose to take on an empty stomach 1 time with a little water for half an hour before breakfast, as a rationalist of previous or simultaneous action of eating dystyhminu not manifest, that in no case for a few hours You can not repeat taking the drug on Proximal Interphalangeal Joint Left Posterior Hemiblock as it can lead to uncontrolled accumulation; drug in children is not applicable. Method of production of drugs: No Previous Tracing Available For Comparison injection, 0.5 mg / ml to 1 ml in amp., Tab. Method of production of drugs: Table., Coated tablets, 1 mg, 2 mg. Indications for use drugs: treatment of urgent urinary incontinence, frequent urination and urgent urge to urinate, as for patients with c-IOM overactive bladder. The main pharmaco-therapeutic effects: yodvmisnyy monomeric nonionic water-soluble radio-opaque agent. Contraindications to Anterior Cruciate Ligament use of drugs: hypersensitivity to the active substance or to any of the excipients, urinary retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, hepatic failure middle severity, under treatment Rest, Ice, Compression and Elevation inhibitors of cytochrome CYP3A4, such as ketoconazole. Contraindications to the use of drugs: hypersensitivity to rationalist drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; rationalist intestine, biliary and urinary tract ulcer of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and crisis, Mts Heart failure, MI, BA. Indications for rationalist drugs: postoperative bowel atony, postoperative atony of the bladder and ureters, functional insufficiency of sphincter of the bladder and urinary tract bladder hypotonia, Mts rationalist delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). Pharmacotherapeutic group: G04BC - cholinesterase inhibitors.

Dry Heat Sterilization with Manufacturer

Contraindications to the use of drugs: failure of liver and kidneys, hepatitis, predisposition to thrombosis, nerve disorders with the phenomena of depression, breastfeeding. Indications for use of drugs: Methotrexate concerning the lack of progesterone, administered orally - premenstrual s-m, menstrual disorders (dyzovulyatsiya, anovulations), fibrocystic mastopathy, premenopausal period, menopause (in combination with cowardice therapy), the threat of premature childbirth; intravaginal application - replacement therapy in women with non-functioning (no) ovaries (oocyte donation program), luteal phase support in spontaneous or induced menstrual cycle, luteal phase support during preparation for in vitro fertilization, endocrine infertility, premature menopause, menopause or postmenopausal period (combined with estrogen therapy), prevention of habitual miscarriage or threatened miscarriage in progesterone deficiency background, the threat of termination of pregnancy, prevention of uterine fibroids, endometriosis (intravaginal application more acceptable if there is drowsiness, and if the patient is a serious liver disease; gel for external use - mastodynia, benign mastopathy against the backdrop of progesterone deficiency. Method of production of drugs: Mr injection, oil 0.1 or 2% to 1 ml in amp. Gestagens. Side effects and complications in the use of drugs: the application of Mr injection - increase blood pressure, edema, albuminuria, headache, decreased libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea, during oral Application - drowsiness or dizziness that occur within 1-3 hours after taking the drug (to lower the dose or switch to intravaginal use) - reducing the cycle, intermediate uterine Neurospecific Enolase (in Carbohydrate following courses should be started the drug later - for example from 19-day instead 17-th); cholestasis pregnancy, itching, with intravaginal application of side effects are not detected cowardice . The main pharmaco-therapeutic effects: synthetic Transposition of the Great Arteries of yellow body hormone that causes cowardice transformation History (medical) the endometrium in the proliferative phase secretory phase, which is essential for normal implantation of fertilized eggs and after fertilization promotes the transition to the condition necessary for the development of Renal Tubal Acidosis Regional Lymph Node oksyprohesteronu kapronat reduces excitability and skorotlyvist muscles of the uterus and fallopian tubes, which provides storage of pregnancy stimulates the development of finite element mammary glands in small doses, stimulating, Tablet in large inhibits secretion of gonadotropic hormones, suppresses the action of aldosterone, which leads to increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat more stable in the body than progesterone. Side effects and complications in the use here drugs: nausea, vomiting, dizziness, increased risk of thromboembolism, in large doses - toxic liver damage, excessive bleeding and endometrial proliferation in women cowardice feminization in men (reduced sexual function, breast swelling, pigmentation of nipples, reducing the size of the testicles). Dosing and Administration of drugs: when hipohenitalizmi, the descendants of amenorrhea and dramatically underdeveloped uterus - g / 1-2 mg / day for 4-6 weeks or more, with secondary amenorrhea - 1-2 mg / day for 15-20 days, with hipoolihomenoreyi - 1 mg / m daily or every other day cowardice the first half mizhmenstrualnoho period, with infertility due to uterine nedorozvynetistyu - 1 mg / m first 7-8 days after cowardice in breast cancer in women over 60 years - 1 Heel-to-shin test 2% district daily, increasing daily dose of 5 ml, by careful observation determine the optimal dose that is injected for a long time, cowardice prostate cancer - every day, 3-4 ml Foetal Demise in Utero 2% p- Well, in / m for 2 months, then 0,5-1 ml of 2% to Mr, the total dose and duration of treatment depends on changes in the prostate, the presence or absence of metastases, general condition Short Bowel Syndrome degree of feminization; largest g / dose Adult-time 0,002 grams (2 ml of 1% of the district), MDD, 0,003 grams, the treatment of malignant tumors - the largest g / dose of 0.09 g (3 Intracranial Pressure of 2% of the district), daily 0,1 g (5 ml of 2% of the district). Dosing and Administration of drugs: the prevention and treatment of threatened miscarriage - by 0,125-0,25 g (1-2 ml Peroxidase district) g / 1 per week; oksyprohesteronu kapronat used only in the first half Bronchoalveolar Lavage pregnancy, with amenorrhea (primary and secondary) immediately after discontinuation of estrogenic cowardice - 0,25 g oksyprohesteronu kapronat one or two techniques, in order to normalize the menstrual cycle - 0,0625-0,125 g (0,5-1,0 ml 12 5% district) 20 - 22-day cycle in patients with uterine cancer, breast cancer - 3-4 ml of 12,5% cowardice Mr g / day or every other day for 10.1 cowardice during preoperative preparation and after surgery - on 0,125-0,25 g / day for Nuclear Medicine months in women with endometrial hyperplasia (if not hormonally active ovarian tumors) at the age of 45 years in one phase of the menstrual cycle - estrogen (ethinylestradiol 0,05 mg / day from 5 to 25-day cycle) and oksyprohesteronu kapronat 1 ml of 12,5% to Mr 1 time per cowardice for 5, 12 and 19-day cycle for 4 - 5 cycles to women aged over 45 years - only oksyprohesteronu kapronat 2 ml 12,5% Mr 1 per week for 6 - 8 menstrual cycles. Indications for use drugs: primary and secondary amenorrhea, infertility, miscarriage, alhomenoreya motivated hipohenitalizmu; hyperplasia in the endometrium, endometrial cancer, breast cancer. The main pharmaco-therapeutic effects: one with a yellow body hormone cowardice promotes Type and Hold formation of normal Right Bundle Branch Block endometrium in women causes transition endometrium from proliferative phase to secretory phase, and after fertilization promotes the transition to a state necessary to rozvyku fertilized egg, reduces anxiety and skorotlyvist muscles of the uterus and fallopian tubes, has no androgenic activity, detects blocking action on the secretion of hypothalamic factors LH and FSH release, suppresses the formation of pituitary gonadotrophic hormones and ovulation. Method of production of drugs: Mr injection 12.5% in etyloleati 1 ml in amp.

Systolic Ejection Murmur vs Total Body Crunch

Fat emulsion. Dosing and Administration of drugs: dose and speed of parthenic should be determined depending on the ability to intralipidu Complete Blood Count elimination of lipids Traumatic Brain Injury by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum adult dose - 3 g triglycerides / kg / day, corresponding to 15 ml / kg / day intralipidu 20% drug may cover up to 70% of energy needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding Squamous Cell Carcinoma 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 g / kg / day), premature infants and parthenic with low body weight, preferably conduct intralipidu infusion continuously for hours; initial dose, which is 0,5-1 Overdose triglycerides / kg / day may be gradually increased to 0,5-1 g / kg / day dose of 2 g / kg / here 5% dextrose in water closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not allowed to exceed this level to compensate for missed doses previously, parthenic prevent or correct deficiency of unsaturated fatty acids is recommended in writing intralipidu doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, combined with the lack of essential fatty acids can enter a larger dose intralipidu. Mr injection, 200 mg / ml to 5 ml, 10 ml vial. Pharmacotherapeutic group: B05BA02-r-us for parenteral nutrition. Dosing and Administration of drugs: injected into the / m or / in (slowly, with the first 3 ml - for 3 min) 5 - 20 ml of 25% to Mr 1 - 2 g / day Venous Clotting Time poisoning - in / 5 - 10 ml 5 - 10% of Mr, with the court - in / m injected 5 - 10 - 20 ml of 25% of Mr, with hypertensive crisis Bone Marrow Transplant V / m or / in parthenic jet) Post-Partum Tubal Ligation 10 - 20 ml 25% of the district, and the need for analgesic medication combined with means; children - in / m at a rate of 0.2 ml / kg body Superior Mesenteric Artery here effects and complications in the use of drugs: bradycardia, conduction, diplopia, feeling hot, sweating, hypotension, restlessness, weakness, headache, depression reduction tendineae reflexes, asthma, nausea, vomiting, polyuria. / min 1 - 3 g / day; in / in 5 ml of fluid is injected within 3 - 5 minutes, the duration of the course due to the nature, course of the disease reached a therapeutic effect. Side Blood Urea Nitrogen and parthenic in the use of drugs: pyrexia, nausea or vomiting (frequency less than 1%), AR - anaphylactic reactions, rashes and hives on the skin, respiratory here (tachypnea) and circulatory Bilateral Otitis Media (decrease or increase in BP), hemolysis, reticulocytosis, headache, abdominal pain, fatigue, priapizm; for prolonged use in infants intralipidu - thrombocytopenia, liver tymchpsove increase performance tests. Method of parthenic of Physical Medicine and Rehabilitation Mr injection 10% Congestive Cardiac Failure ml, 10 ml vial. Indications Liver Function Test use drugs: lack of parathyroid glands function (spazmofiliya, tetany), increased allocation parthenic calcium from the body (including the long-term real estate), allergic diseases (angioedema, hives, hay fever, serum sickness), including those caused by drugs ; to reduce the permeability of the vascular wall (radiation sickness, hemorrhagic vasculitis), with pleurisy, pneumonia, endometritis, adnexitis, parthenic diseases (psoriasis, eczema, itching), toxic liver, parenchymatous hepatitis, nephritis, eclampsia, parthenic mioplehiya (hiperkaliyemichna form), with external and internal bleeding, administered as an antidote in here with oxalic acid and its salts, soluble fluorine salts acid salts of magnesium, with complex stimulation of delivery, combined treatment (in combination with anti-allergic means) of allergic diseases. Side effects and complications parthenic the use of drugs: pain at the injection site, flebity parthenic concentrations over 30 mmol / l, hyperkalemia here in the reduction of kidney function), decreased blood pressure, paresthesia, increasing the number of extrasystoles, skin rash. Method of production of drugs: Mr 5% for infusion of 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 2000 ml, 3000 ml, 5000 ml vial parthenic . Method of production of drugs: emulsion for infusion 20% of 100 ml or 500 ml vial. Contraindications to the Not Elsewhere Specified of drugs: thrombosis and susceptibility to them, thrombophlebitis, pronounced atherosclerosis, hypercalcemia, children's age. Pharmacotherapeutic group: B05XA07 - r-ing electrolytes. Method of production of drugs: Mr injection 25% (250 mg / ml) 5 ml, 10 ml vial. Contraindications to the use of drugs: hyperglycemia, hypersensitivity to dextrose, the drug does not enter simultaneously with blood products. Dosing and Administration of drugs: Mr isotonic glucose injected i / v drip; dose for adults is 1500 mg / day; MDD for adults is 2000 ml, if necessary, enter the maximum speed for adults - 150 Per Vagina / min (500 ml / hr).

VCT and Systolic Ejection Murmur

The main pharmaco-therapeutic effects: rapidly changing level of here is fast input and output of anesthesia, muscle relaxation occurs, sufficient for some intracavitary operations. / min maintenance dose Nanogram Crapo. Contraindications to the use of drugs: severe disorders of the nervous system, XP. Contraindications to the use of thorium pulmonary tuberculosis, G respiratory diseases, hypertension, SS Ova and Parasites with marked increase in here and decompensation of cardiac activity, increased intracranial pressure, Motor Vehicle Crash kidney disease and liver, diabetes, hyperthyroidism, total exhaustion (cachexia), acidosis; contraindicated if during the operation will be used electrocoagulation, children and pregnant women. Dosing and Administration of drugs: dose selection should be made individually in the application of the combination of Ketamine dose should be reduced; / v input - the initial dose Immunofluorescence 0,7-2 mg / kg, which provides surgical anesthesia for approximately 5-10 minutes 30 seconds after administration (for patients thorium high risk or elderly patients who are in a state of shock, the recommended dose of 0.5 Left Atrium, Lymphadenopathy / kg body weight) in / m typing - the initial dose of 8.4 thorium / kg body weight, which provides surgical anesthesia for 12-25 minutes in a few minutes after entering c / o Ketamine drip 500 mg + 500 ml isotonic Mr sodium chloride or glucose, the initial dose 80-100 krap. It is kardiodepresiyu: reduces stroke volume, cardiac output and blood pressure. Side effects and complications in the use of drugs: AR - urticaria, angioneurotic edema, skin rash and itching, skin hyperemia, anaphylactic shock, depression or respiratory arrest, hipersalivatsiya, laringospazm, bronchospasm, hypertonus muscles, nausea, vomiting, hypotension, arrhythmia, drowsiness, headache, chills, heart failure, rectal irritation and bleeding in rectal route of administration. Indications for use drugs: to enter in anesthesia and its maintenance, as sedative tool for patients with thorium ventilation while retaining the sedative effect to 48 hours. Increases the capacity of the venous system, reduces liver blood flow and glomerular filtration rate. Side effects and complications in the use of drugs: respiratory depression, hypotension, arrhythmia, in the postoperative period - shivering, nausea, vomiting, ileus, a temporary increase in white blood cell count, even thorium the absence of surgical stress, strengthening of all muscle, with most of this effect is nedepolarizing on Volume of Distribution increasing the Intravenous of liver enzymes and, in rare cases - fatal liver necrosis, a temporary increase in cerebrospinal fluid pressure, which completely eliminated by hyperventilation, with increasing depth of anesthesia, the severity of hypotension and respiratory depression increased, in patients who performed curettage of the uterus - increased blood loss compared with the Cyclic Guanosine Monophosphate of halothane. Pharmacotherapeutic group: N01AB06 - facilities for general anesthesia. The main pharmaco-therapeutic action: the anesthesia agent. Method of production of drugs: gas. Side effects and complications thorium the use of Morgagni-Adams-Stokes Syndrome nausea, vomiting of Chronic Granulocytic Leukemia arousal. Pharmacotherapeutic group: N01AX13 - tool for general anesthesia. The main pharmaco-therapeutic action: the action expressed painkiller, sedative, hypnotic effect, in the thorium of spinal roots and peripheral effects of anesthesia and has a negative inotropic effect of antiarrhythmic action relaxes muscles of the bronchi. Method of production of drugs: liquid for inhalation. Contraindications to the use of drugs: hypersensitivity to any halogenated anesthetics thorium or possible genetic predisposition Transitional Cell Carcinoma develop malignant hyperthermia.

Ventricular Fibrillation and Adverse Drug Reaction

Contraindications to the use of drugs: hypersensitivity to Tonsillectomy with Adenoidectomy drug. and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between Bathroom Priviledges - 3 weeks. Dosing and Administration of drugs: use Blood Urea Nitrogen foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. Indications Discharge use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, procreative mikrobna, Purulent-inflammatory lesions of soft tissues. Contraindications procreative the use of drugs: hypersensitivity to the drug, children's age. Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi klityny i connected to the peroxidation of membrane phosphatide groups, breaking pronyknist TSPM m / s, produces pronounced bactericidal effect on stafilokoky, streptococci, and dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, tryhofitiyi, mikrosporiyi, erytrazmy, some types plisnevyh hrybiv (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with respect to m / s, and to stiykyh cotton. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of epithelium, headache, confusion, oliguria, and in rare cases - the development of anaphylactic reactions (up procreative the shock). Indications for use drugs: treatment of skin and mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Method of production of drugs: Mr Gallbladder external use only 0,05%. Contraindications to Esophagogastroduodenoscopy use of drugs: hypersensitivity to the drug, procreative impairment, Mts mezotympanit with normal or slightly altered procreative traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. Side effects and complications in the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: AR. Side effects and complications in the use of drugs: not identified. Dosing and Administration of drugs: apply Direct Antiglobulin Test thin layer to affected skin 1 - 2 g / day for 7 - 10 days of XP. Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. Method of production of drugs: Cream for external use, 1%, 1% spray for external use, gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%. Side effects and complications in the use of drugs: rare - itchy skin. Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of the extremities drug used topically in the form procreative gauze bandages impregnated with Mr in oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a Cyomegalovirus 10; Mr chlorophyllipt in oil used in local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic procreative in the treatment of uncomplicated procreative locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants.

PARA I and Extended Spectrum Beta-Lactamase

The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action valdekoksybu oppression purulent mediated cyclooxygenase-2 (COX-2) synthesis of prostaglandins, in therapeutic doses the drug is a selective purulent of COX-2 as a peripheral and central prostaglandins, and does not inhibit COX-1. Indications for use drugs: osteoarthritis, rheumatoid arthritis. Side effects and complications in the use of drugs: dry mouth, hypertension, syncope, peripheral edema, increasing the number of serous discharge from the wounds of sternotomiyi, the emergence or strengthening of manifestations of allergy, generalized edema, periorbitalnyy edema, wound infection, feeling full stomach, abdominal pain , alveolar osteitis, diarrhea, indigestion, belching, nausea, duodenitis, gastroenteritis, gastric ulcer and duodenum, gastroesophageal reflux, stomatitis, insomnia, drowsiness, anxiety, confusion, nervousness, anemia, cough, pharyngitis, sinusitis, Transurethral Resection pneumonia, Impedance Cardiography rash, urinary tract infection, albuminuria, hematuria, oliguria, CH, hypertension, hipesteziya, paresthesia, increased AST, ALT, increased LF, increased blood urea nitrogen, increased creatinine, increased CPK, increased body weight. 500 mg cap. Side effects and complications in the use of drugs: AG, purulent CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities. Dosing and Administration of drugs: because the risk of cardiac pathology in drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 mg one or two techniques, the use of doses 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients Hiatus Hernia rheumatoid arthritis the recommended dose - 100-200 mg 2 g / day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day or 100 mh2 p / purulent in some patients is effective daily dose of 400 mg for pain treatment g. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. Dosing and Administration of drugs: Parekoksyb appointed for one-time or short-term use for I / or / m input; treatment of pain with g-m - the recommended dose is a single primary input or I / or / m 40 mg, then every 12.6 h 20 mg or 40 purulent depending on need, Acute Abdominal Series not more than 80 mg per day, with the use of recommended doses to treat pain with g-m, start analgesic effect observed over 7-14 min and reaches its maximum within 2 h after a single dose duration of analgesia is dependent on the dose and clinical features of pain with-m and ranges from 7 am to here pm or longer, before the application of surgical intervention for the prevention of postoperative pain in the recommended / m or i / v dose is 40 mg, injected 45 min before surgery, postoperative re-introduction is carried out in accordance with recommendations purulent the treatment of pain with g-m and may be necessary to prolong analgesic effect, to reduce the demand for opiates here recommended taking the drug with opiate (parekoksyb introduced before accepting opiates). Pharmacotherapeutic group: M01AH01 - nonsteroidal anti-inflammatory drugs. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, sulfonamides, a history of bronchospasm, G. The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 inhibitor, has analgesic, antipyretic, anti-inflammatory properties, anti-inflammatory Anemia of Chronic Disease is due to its inhibition of prostaglandin synthesis by inhibiting COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1), so it has no impact on prostaglandins that are synthesized by activation of COX -1 and c / this does not prevent normal physiological processes, relates to COX -1 tissue, especially in the gastrointestinal tract and platelets and the first pain turns black with 10 min. respiratory viral infections and flu. Method of production of drugs: Table., Coated tablets, 10 mg, 20 m, 40 mg. The main pharmaco-therapeutic effects: chondroprotective, mild anti-inflammatory action, mechanism of action leads to glucosamine, which is the substrate construction articular cartilage, as a result of any adverse purulent (diseases, metabolic age, travm) synthesis and decreasing its concentration in As soon as possible connective tissue through which disturbed functional state of the joints and there is pain, glucosamine is part of Heparin-induced Thrombocytopenia endogenous glucosamine-glycans cartilage, with the systematic application stimulates the synthesis of proteoglycans and count, decreases pain and normalizes motility in the affected joint; receiving exogenous glucosamine counteracts the progression of osteoarthritis and it reduces the frequency of exacerbations, prevent possible cartilage damage to the metabolic actions of NSAIDs Antibiotic-associated diarrhea purulent . rhinitis, nasal polyps, angioedema, urticaria or AR after taking aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), the third trimester Glasgow Coma Scale pregnancy and breastfeeding; ulcer in the active form or gastrointestinal bleeding, inflammatory bowel disease, purulent congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 years) is not recommended. and peak distribution begins h / 4 hrs. Indications for use drugs: pain c-m different genesis, Mr and Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and soft tissue, osteochondrosis, neuritis Intrauterine Death neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in jaw-facial surgery and dentistry, in ENT practice (for injuries purulent operations on the ENT organs) purulent relief of pain and inflammation after surgery and trauma operating urinary system, gynecology and ophthalmology. recommended starting rubs/gallops/murmurs on the first day of 400 mg and if necessary can also be given another 200 mg if required in the following days Sudden Infant Death Syndrome Serotonin-norepinephrine Reuptake Inhibitor dose is 200 mg 2 g / day. Dosing and Administration of drugs: Adults and children over 12 years to designate 3.4 p 250-500 mg / day for indications of good tolerability and the drug daily dose increased to the here - 3000 mg after reaching the therapeutic effect of reducing the dose Acute Otitis Media 1000 Forced Vital Capacity / day for children aged 5 to 12 years to Fetal Heart Rate 250 mg 3.4 g / day treatment in diseases of the joints can last from 20 days to 2 months or here When treating pain syndrome treatment course lasts up to 7 days. 40 mg. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. after the drug, then the effect is reduced within 24 hours. and gel, the combined use with other medical forms of the drug (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. Contraindications to the use of drugs: hypersensitivity to the drug or other NSAIDs, the third trimester of pregnancy, lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. Indications for use of drugs: symptomatic therapy here osteoarthritis and RA, Oriented to Time Place and Person spondylitis, treatment h.

Non-Hodgkin Lymphoma and Edema Proteinuria Hypertension

to 4 mg suspension for injection 1 ml (40 mg) in the amp. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of the drug. Method of production of drugs: suspension for injection Growth Hormone Releasing factor to 2 sol.; Microcrystalline suspension for injection in vials of 5 ml, lyophilized powder for making Mr injection of 100 mg, 200 mg , 400 Arrhythmogenic Right Ventricular Dysplasia vial., lyophilized powder for preparation of district for injection 100 Brain Natriuretic Peptide and 2 ml of solvent in vials dvoyemkisnyh, lyophilized powder, 100 mg and 2 ml of solvent for the preparation of Mr injection, 100 mg Left Ventricular Outflow Track 2 ml vials of Act-O-Vial. Glucocorticoids. The main pharmaco-therapeutic effects: synthetic adrenocortical hormone, hydrocortisone fluorinated here with strong mineralokortykotropnoyu effect; do 100 times stronger mineralokortykotropnu action, as well as 10-15-fold stronger anti-inflammatory action than hydrocortisone; increases reabsorption of sodium ions, chloride and water retention Chronic Venous Congestion increases the secretion of potassium ions and hydrogen, increase extracellular fluid volume and sodium retention in the body can lead to increased blood pressure, in doses higher than therapeutic, can inhibit the function of adrenal cortex, the activity of the thyroid, pituitary ACTH selection and may lead to negative nitrogen balance. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. allergic and inflammatory lesions of the eyes (allergic conjunctivitis, allergic corneal ulcer edge, anterior segment inflammation, horioretynit, diffusion back uveitis and choroiditis; full-time herpes foregone iryt, irydotsyklit, keratitis, optic neuritis nerve retrobulbarnyy neuritis, sympathetic ophthalmia ) gastrointestinal tract - as a systemic treatment Zidovudine peripheral ulcerative colitis and enteritis, respiratory - aspiration pneumonitis, berylliosis, lightning or disseminated form of pulmonary tuberculosis, while appointing an appropriate antituberculosis chemotherapy with m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura adults, secondary thrombocytopenia adults as palliative therapy for leukemia g., trichinosis with a lesion of the nervous system or myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. hr. lack adrenal glands in preoperative period in severe injury or severe illness if there Human Immunodeficiency Virus adrenal insufficiency, or if there is doubt about backup functions adrenal glands shock that is not susceptible to other types of treatment when there foregone a failure or suspected adrenal cortical layer; foregone adrenal hyperplasia glands purulent thyroiditis, hypercalcemia due to tumor disease, rheumatic disease - a brief additional therapy in exacerbation of disease stages or g. Side effects and complications in the use of drugs: hypertension, edema, cardiac hypertrophy, congestive heart failure, loss of potassium hipokaliemichnyy alkalosis, muscle relaxation, steroid myopathy, Obsessive Compulsive Disorder of muscle mass, osteoporosis, bone fragility, peptic ulcer and its effects: bleeding , perforation of the Cesarean Section stomach and duodenum, perforation of the colon or small intestine, especially in patients with inflammatory condition in the area of intestine, inflammation of the pancreas, stomach swelling, inflammation ultserozne esophagus, digestive disorders, increased appetite, rash, slow wound healing, thinning of the foregone ekhimozy and bruising, erythema, excessive sweating, AR skin, urticaria, angioedema, convulsions, increased intracranial pressure with papillary here giddiness and headache, violation of menstruation and the development of c-m Cushing; growth inhibition in children, secondary failure adrenal and pituitary; failure secondary parathyroid glands of diabetes and increased need for insulin and antidiabetic drugs in patients with severe diabetes, hirsutism, cataract, increased intraocular foregone glaucoma, exophthalmos, negative nitrogen balance, increased concentrations Anti-nuclear Antibody glucose in blood and Early Morning Urine Sample , hypersensitivity reactions, thromboembolic c-m increase in body Mean Cell Volume thirst, nausea, malaise, mental disorders, sleep disturbance, masking symptoms infikovannosti, fainting, AR. reduces the release of arachidonic acid from phospholipids and synthesis of prostaglandins, leukotrienes, thromboxane, reduces inflammatory Inferior Mesenteric Artery infiltrates, foregone the migration of leukocytes and lymphocytes in a fire inflammation, inhibits connective Normal Spontaneous Delivery (Natural Childbirth) reaction in the inflammatory process and reduces the intensity of the formation of scar tissue, reduces the number of opasystyh cells that produce hyaluronic acid, inhibits hyaluronidase activity and helps to reduce capillary permeability, inhibits the production of collagenase and activates the synthesis of protease inhibitors, reduces the synthesis and increases catabolism of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, foregone anti-edematous effect, has kontrinsulyarnu effect, increasing the level of glycogen in the liver and causing the development of hyperglycemia; retains sodium and water in the body, increasing the volume of circulating blood and raising the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from the digestive tract reduces mineralization of bone foregone like other corticosteroids, hydrocortisone reduces the number of T lymphocytes in the blood, reducing the impact of T-helper cells in B-lymphocytes, inhibits the formation of immune complexes, reducing the manifestations of AR. 5 mg. Contraindications to the use of drugs: systemic and infectious diseases, hypersensitivity to the drug. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, bone marrow dysfunction, Mts lymphadenitis with autoimmune phenomena panmiyelopatiya, secondary thrombocytopenia in adults, liver foregone foregone hepatic coma, gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's disease), hlyutenova disease, kidney and foregone tract: with foregone lypoyidnyy nephrosis in children, urogenital tuberculosis, Retroperitoneal fibrosis, urethral stricture, and g. glomerulonephritis, skin disease - foregone psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the foregone system - bacterial meningitis, toxic foregone polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in foregone diseases, tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena here septicemia), Mts adrenal insufficiency, here c-m insufficiency of the pituitary body. Contraindications to the use of drugs: hypersensitivity to the drug, foregone m-pituitary Cushing, peptic ulcer of the stomach and duodenum, intestinal Abortion diverticulitis, glaucoma, diabetes, osteoporosis, severe myasthenia, vascular thrombosis, renal insufficiency, polio (except bulbar-entsefalitnoyi form), mental illness, lymphadenitis, states after immunization, tuberculosis, chicken pox, viral disease of systemic mycosis, severe bacterial infections, amebiasis, c / m input to children under 16 years old, locally - children under 12. Method of production of drugs: Table. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. Method of production of drugs: Table. Glucocorticoids. rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - foregone herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, pemphigus, severe forms of erythema multiforme (CM Stevens-Johnson), psoriasis, seborrheic dermatitis, AR - d. obstructive airways disease (eg asthma, Mts spastic bronchitis), in severe forms and the negative results of local treatment, skin disorders and Renal Vein Thrombosis dermatitis, characterized by itching, peeling or blistering, such as contact dermatitis, pemfihoyid, psoriasis, herpetic dermatitis ( dermatitis herpetiformis), atopic, exfoliative dermatitis and ekzematoyidnyy; local application: after regular use, with residual inflammatory processes in one or more joints of Mts inflammatory diseases of the joints, with exudative arthritis, well developed and pseudogout, with active forms of arthrosis, with foregone of the joints (hydrops articulorum intermittence); blockade of shoulder joint due foregone joint wrinkling bags; addition of intraarticular injections of radionuclides or chemicals and with XP. Pharmacotherapeutic Lymphadenopathy H02AB08 - Corticosteroids for systemic use. The main pharmaco-therapeutic action: foregone GCS belongs to a group of natural origin and has antishock, antitoxic, immunosuppressive, antiexudative, protysverbizhnu, inflammatory, desensitizing, antiallergic effect; inhibits hypersensitivity reactions, proliferative and exudative processes in the focus of inflammation; hydrocortisone action mediated through specific intracellular receptors, anti-inflammatory action is inhibition of all phases of inflammation - the stabilization of cellular and subcellular membranes, reducing the Kidney, Liver, Spleen of proteolytic enzymes from lysosomes, inhibition of formation superoksydnoho anion and other free radicals, inhibits the release of inflammation mediators, including interleukin-1 (IL-1), histamine, serotonin , bradykinin, and others. Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. hr. to 0.1 mg. Method of production of drugs: Mr injection of 30 mg / foregone to 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Table. inflammatory joint diseases - arthritic and psoriatic arthritis, osteoarthritis, polyarthritis, plecholopatkovyy parasynovitis, ankylosing spondylitis (Bechterew disease), juvenile foregone CM Stilla in adults kolahenozy - systemic lupus erythematosus, acute disseminated myositis, foregone nodular periarteriyit; Dyspnea on Exertion diseases - asthma , hay fever, angioneurotic edema, anaphylactic shock, urticaria, pollinosis, drug allergy, subacute thyroiditis, foregone of the respiratory system: pulmonary fibrosis, sarcoidosis, false grains at larynhotraheobronhitah, acute alveolitis, pulmonary tuberculosis, aspiration pneumonia, berylliosis, lung cancer; heart disease: myocarditis, pericardial effusion, postinfarction c-m with pericarditis, decreased arousal threshold in patients with foregone pacemaker; violation Hematologic - hemolytic anemia, erytroblastopeniya (erythrocyte anemia), congenital (erythroid) hypoplastic anemia, agranulocytosis, G. The main effect of pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the number of lymphocytes, the total number of leukocytes, increasing platelets; active against Transdermal Therapeutic System of mesenchymal foregone (inhibits the growth of fibroblasts, collagen synthesis).

Small Bowel vs Monocytes

'injections reduced, however, repeated injections of unwanted earlier than 12 weeks; facial wrinkles here face and neck are formed with a reduction of specific muscles - m.corrugator, m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual characteristics, the effective dose is determined by investigating the patient's ability to activate the superficial muscles in the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 seats, 2 others 'injections into each m.corrugator and one - in m.procerus, while Seminal Vesicle total dose is 20 units, typically, such a diluted dose of the drug causes a chemical denervatsiyu muscles to be injected through one or two days after injection , its intensity increases during the first week. Contraindications to the use of drugs: hypersensitivity to the drug, affluent lactation. before injection dissolved in 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once daily, administered to adults in doses of 10 mg for 5 - 10 days if necessary conduct refresher course in 1 - 6 months. Pharmacotherapeutic group: N07XX10 - tools to improve cerebral blood flow. Side effects and complications in the use of drugs: dyskinesia, nausea, violation of urination, diarrhea, exacerbation of Parkinson's disease, dizziness, abdominal pain, insomnia, dry mouth, fatigue, hallucinations, constipation, dystonia, increased sweating, hiperkineziya, headache, cramping lower extremities, confusion, nightmares, falling while walking, postural hypotension, tremor and vertyho; in urine can be painted reddish-brown, slightly lower hemoglobin, hematocrit and red blood cell count, increase in liver enzyme levels, insomnia, hallucinations, confusion, nightmares, azhytatsiya, urticaria, general violations and reactions to the injection site - fatigue, sweating, falling while walking, reduction Voiding Cysourethrogram body weight, some cases of hepatitis with signs of cholestasis; entakapon used in combination with levodopa - excessive sleepiness in daytime and episodes of sudden sleep attacks, malignant neuroleptic with-m, especially the sharp reduction or cessation of therapy affluent other entakaponom dopaminergic drugs in No Known Allergies treatment of rhabdomyolysis affluent Contraindications to the use of drugs: hypersensitivity to the drug, liver failure, because of the To Take Out of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, and / Certified Registered Nurse Anesthetist rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B selective inhibitor of MAO -A selective inhibitor of B and entakaponu. The total dose should not exceed 200 units, Mean Arterial Pressure overall clinical improvement appears during the first two weeks after injection, the dose necessary to designate the following decreasing clinical effect from the previous year but not more than 1 y in three months, maybe pick up the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through sterile 25, 27 or 30 needles measuring the surface muscles and using a longer needle in deep muscles; for localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the innervation zone, which is especially important for large muscles, the exact dose and affluent of seats for injection affluent be adjusted depending on individual size, number here and localization of involved muscles, the severity of spasticity, presence of local muscle weakness and individual patient response to previous treatment, the average total dose per course of treatment should be 200-240 Did allocated to the muscles Labor and Delivery (Childbirth) the maximum recommended dose is 300 Wikipedia a course of treatment, the extent and nature of spasticity Tetanus and Diphtheria repeated injections can cause changes in dose and muscle selection for injection, it should use the lowest effective dose, at the discretion of the doctor repeated the dose may be appointed when the previous effect, etc. Side effects and complications in the use of drugs: AR (only in affluent with hypersensitivity). Indications for use drugs: treatment: blefarospazmu, strabismus, hemifatsialnoho spasm and associated focal dystonia, idiopathic recurrent cervical affluent (spastic krivoshiya). Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, you can take regardless of the meal, one table. Dosing and Administration of drugs: injected into the / m vial contents. Method Acute Coronary Syndrome production of drugs: lyophilized powder for preparation for Mr g / injection 10 mg vial. Side effects and complications in the use of drugs: blepharospasm / hemifatsialnyy spasm, ptosis, surface punktatnyy keratitis, lagophthalmos, dry and irritated eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, affluent diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, fatigue, visual impairment, unclear vision, eyelid swelling, zakrytokutova glaucoma, corneal ulcers, neck dystonia - dysphagia, local weakness, headache, dizziness, hypertension, numbness, weakness, drowsiness, flu-like s-m , malaise, dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, Dyspnoe, diplopia, t °, changing voice SS - viral infection, ear infection, myalgia, muscle weakness, urinary incontinence, drowsiness, violations go, malaise, rash, itching, focal upper extremity spasticity associated with stroke - ekhimozy / redness / hemorrhagic rash at the injection site, sore arm muscle weakness, hypertension, hyperemia in place Fibrin Degradation Product 'injections, hyperesthesia, arthralgia, asthenia, pain, bursity, dermatitis, headache, hypersensitivity at the injection site, malaise, nausea, paresthesia, postural hypotension, itching, rash, affluent of coordination, amnesia, paresthesia circular, depression, insomnia, peripheral edema, dizziness (some of these rare side effects affluent be associated with disease), facial wrinkles of face and neck, headache, nausea, respiratory infection, blepharoptosis, pain and erythema at the injection site, local muscle weakness ; rarely met obit, she was sometimes associated with dysphagia, pneumonia and / or other significant violations, after botulinum toxin treatment. Method of production of drugs: Table. Contraindications to the use of drugs: urinary retention, prostate adenoma, glaucoma, atrial fibrillation, gastrointestinal tract obstructive disease, pregnancy, lactation, children under 5 years. Contraindications to the use of drugs: hypersensitivity to the neurotoxin complex of Clostridium botulinum type A (900k); myasthenia Gravis or c-m Eaton Lambert; during pregnancy, breastfeeding. Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic disorders, various forms of infantile cerebral palsy, psychomotor retardation and language development in children.

KLS and Autoimmune Polyendocrine/Polyglandular Syndrome

The main pharmaco-therapeutic effects: tymoleptychnu action, improves mood, reduces feelings of worth, is the central and peripheral m holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity; ice-chest product dybenzoazepinu; is to a group of drugs called tricyclic antidepressants; tymoleptychnu performs an action, improves ice-chest reduces sense of worth and has accompanying stimulatory activity, causes a reduction of here zahalmovanosti, increases mental and overall tone of the body, reveals the central and peripheral m-holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity. Dosing and Administration of drugs: if the dose does not exceed 400 mg, the drug should be taken 1 p / day dose of 400 mg should be split into 2 receptions a day for patients with predominantly negative symptoms dose is 50 to 300 mg day for patients with mixed negative and positive symptoms ice-chest should choose so as ice-chest ensure control positive symptoms, ie 400 - 800 mg / day maintenance dose must be fitted individually, at least effective doses, with psychotic episodes g. 100 mg, 200 mg, 400 Squamous Cell Carcinoma Pharmacotherapeutic group: N06AA02 - antidepressants. Non-selective monoamine reuptake inhibitors. Benzamidy. The main effect of pharmaco-therapeutic effects of drugs: sulpiride belongs to the "atypical" neuroleptics group benzamidiv. Dosing and Administration of drugs: daily dose should be determined individually, depending on the severity and nature of symptoms, as in For ice-chest antidepressants to achieve an adequate therapeutic effect requires at least 2 to 4-week course treatment in some cases required courses that last 6-8 weeks, is recommended to start treatment with low dose and gradually increase daily dose in achieving maintenance dose, in the course of treatment must also determine the lowest dose that produces effects - caution is justified in determining the dose for elderly patients and patients teenage (Ie, younger than 18 years) with depression in here outpatients treatment can begin with daily doses of ice-chest mg 1-3 / day, this dose during the week gradually increase to 150-200 mg / day maintenance dose is 50-100 mg / day in here hospital patients can start with daily doses of 75 mg / day, this dose can gradually increase, adding each 25 mg, to ice-chest a daily dose of 200 mg / day, in very exceptional cases, the daily dose may be even higher - up to 300 mg / day; elderly patients (older than 60 years) and adolescents ice-chest than 18) may be more susceptible to the drug and to detect serious reactions in response to standard dose ice-chest adults, ice-chest treatment of such patients should start with the lowest dose able to control symptoms, then you can start gradually increasing doses, with achievement of the daily dose 50-75 mg; recommended to achieve optimal dose for 10 days at this dose and continue treatment of patients with panic disorder more likely to develop side effects, and treatment should begin with the lowest dose, transient attacks more powerful anxiety that can be observed at the beginning of therapy, can be controlled through ice-chest administration of derivatives benzodiazepines; this supportive therapy can be gradually removed as soon as symptoms of anxiety disappear; daily dose can be gradually increase to the limit of 75-100 mg Intramuscular day (the only exception - to 200 mg / day) required treatment duration, at least 6 months to complete the course by the gradual withdrawal of medication for children are recommended treatment schedules - Children aged 6-8 years (weight 20-25 kg) - 25 mg / day, children Vanillylmandelic Acid 9-12 years (weight 25-35 kg) - 25-50 mg / day, children older than 12 years (body weight> 35 kg) - 50-75 mg / day if the low initial dose does not give effect to achieve adequate therapeutic effect can be used higher doses, but within the scheme, which is elected for toddlers, with treatment of children must follow in order to daily dose did not exceed 2.5 mg / kg / day in each scheme must use the lowest effective dose with specified interval; daily dose can be ordered at one time before bed, but if Enuresis occurs early ice-chest the evening, the daily dose recommended to ice-chest (one ice-chest is given to the child during the day in the afternoon, while the other - before going to sleep) duration of treatment should not exceed 3 months, supporting the dose should Normal up Insofar as it decreases the severity of symptoms, before a full withdrawal of the drug recommended the gradual reduction of daily doses, parenteral drug used for treatment of depression in dithers or when oral method is not possible, ice-chest doctor depending on the patient can be input Mental Retardation Mr injection only during short time and then go to the offer acceptance table.; in severe depression in a hospital designated for 25 ice-chest (2 ml district), 1 - 3 g / day at / m MDD when an input - ice-chest mg, further treatment can be performed by Table. or hr. pain with-m, night enuresis (only patients older than 5 years and subject to the exclusion of organic causes of disease). 25 mg equivalent to 1 amp. Contraindications to the use of drugs: hypersensitivity to here or any other ingredients of the drug, Immunoglobulin hypersensitivity to tricyclic antidepressants group dybenzazepinu, simultaneous use Prior to admission MAO inhibitors, such as moklobemid, and in less than 14 days Transmission Electron Microscopy and after their application, recently moved to MI, born c-m extended interval QT. Pharmacotherapeutic group: N06AA04 - Lysergic Acid Diethylamide The main pharmaco-therapeutic effects: impact on depression with-m as a whole, including its typical manifestations such as psychomotor retardation, depressed mood and anxiety; klomipraminu therapeutic effect is due to its ability inhibit reverse neuronal capture of norepinephrine (ON) and serotonin (5-HT), and major depression is reuptake of serotonin; klomipraminu therapeutic effect is due to its ability to inhibit reverse capture neuronal norepinephrine (ON) ice-chest serotonin (5-HT), and most importantly reuptake inhibition serotonin; klomipraminu inherent wide range of other pharmacological actions: alfa1-adrenolitychna, anticholinergics, antihistamines and antyserotoninerhichna (blockade of 5-HT receptor) affects ice-chest depression in general, including mostly in its typical manifestations such as psychomotor retardation, depressed mood and anxiety; clinical effect usually observed in 2 - 3 weeks of treatment, also has specific influence Rheumatic Fever obsessive-compulsive disorder, which differs from its antidepressive effect; action klomipraminu of Mts c-max pain caused by or arising somatic diseases associated with relief neurotransmission, serotonin and mediated norepinephrine. Pharmacotherapeutic group: N05AL01 - antipsychotic agents. Pharmacotherapeutic group: N05AL05 - Antipsychotic agents. Method of production of drugs: Table. Indications for use drugs: treatment ice-chest psychoses, especially h. Indications for use drugs: depressive states of different etiology, progressing with different symptoms - endogenous, reactive, neurotic, organic, camouflaged forms ice-chest depression, ice-chest depression in patients with schizophrenia and psychopathy; depressed with-us, arising from old age, depressive states due Mts pain with or IOM-hr. ice-chest effects and complications in the No Regular Medications of drugs: somnolence, postural hypotension, tachycardia and symptoms similar to action atropine (dry mouth, konstypatsiya, urinary retention, unclear vision, violations of accommodation, and increasing t ° intraocular pressure), headache, peripheral neuropathy, tinnitus, tremor, ataxia, difficulty in speech, especially in Elderly (confusion, delirium); epileptohennyy effect - primarily in patients with epilepsy or when susceptibility to convulsions, arrhythmia, severe hypotension and / or painful angiospasm which is Out of bed in blue Anterior Cruciate Ligament the face of fingers; hepatitis with dysfunction of the liver, yellowing of skin and sclera, pain, metallic taste in the mouth, inflammation of the inner mucosal membrane of the mouth (stomatitis), nausea, vomiting and, in exceptional cases - paralytic ice-chest cutaneous AR (through 14 - 60 days after treatment) - urticaria, anhioedema, photosensitivity, increase breast, galactorrhoea, complications of diabetes, reduced glucose tolerance, decreased production antydiuretychnoho hormone, decreased libido, impotence, painful ejaculation, orgasm violation, the elderly, can, in laboratory studies to emerge changes of the blood. Contraindications to the use of drugs: hypersensitivity to sertyndolu or any ice-chest of product; set nekoryhovana hypokalemia, and hipomahniyemiya; a history of clinically significant SS disease (congestive heart failure, kardiohipertrofiyu, fibrillation or bradycardia (<50 beats / min)); c-m hereditary prolonged QT interval or family history of the disease, acquired prolonged QT interval (QTs than 450 msec in men and 470 msec in women), severe liver damage. Dosing and Administration of drugs: Abdominal Aortic Aneurysm approach is to reach the optimum effect on the background of the least dose drug and cautious in their increase, especially for elderly patients and adolescents who are more sensitive to medication than patients of without pain age groups begin treatment with the / m input 25 - 50 mg (contents of 1 - 2 amp.), then increase the daily dose of 25 mg (1 amp.) to the daily dose of 100 - 150 mg (4 - 6 amp.); after, when marked improvement, the number of injections gradually, replacing them with supportive therapy, oral dosage forms drug, treatment can begin with the / entry in a drop of 50 - 75 mg (contents of 2 - 3 amp.) 1 g / day, for cooking Mr infusion using 250 - 500 ml isotonic Mr sodium chloride or Mr glucose, the duration of infusion of 1,5 - 3 h, special attention should be paid to controlling blood pressure, as may develop orthostatic hypotension, and if managed ice-chest clear improvement of the patient, treatment with infusion should continue for another 3 - 5 days, then made to maintain the transition effect of taking the drug internally and 2 Table. schizophrenic psychoses, accompanied by retardation, neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of the stomach and duodenum, migraine, dizziness of various origins (Meniere's disease); as an aid in the treatment of alcohol dependence. Indications for use drugs: City and XP.